Gene therapy may treat obesity
By Times of India,
Times of India
| 03. 10. 2009
Alarmed by the rise in obesity, researchers are examining the possibility of injecting a gene directly into one of the critical feeding and weight control centres of the brain.
"Obesity significantly increases the risk for diabetes, cardiovascular disease, stroke and some cancers," said Matthew During, the study's co-author and professor at Ohio State University Medical Centre.
"Our findings represent a promising new treatment for obesity that could ultimately provide a much safer and more effective approach than some conventional therapies," he said.
Scientists have discovered that a particular gene, BDNF, when active in the hypothalamus, can result in improved insulin sensitivity, reduced fat mass and weight loss.
Lei Cao, a co-author and assistant professor of molecular virology, immunology and medical genetics, said the study involved injecting the BDNF gene in normal mice, diabetic mice and mice fed with a high fat diet, to determine how the gene transfer would affect their weight.
"The gene was active in the overweight mice but as they lost weight, the gene expression was essentially 'dialed down,' using a novel RNA interference approach, thus stopping...
Related Articles
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Émile P. Torres, Truthdig | 02.26.2026
It’s well known that Jeffrey Epstein was a super-wealthy pedophile with an extraordinary network of powerful friends: tech billionaires, politicians and academics. But few people know that he was also a transhumanist — someone who believes that we should...
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...